Abstract
BACKGROUND
Medication-related problems are prevalent in older adults and adversely affect the quality of care. It has been suggested that racial differences exist in medication use. Most efforts to evaluate the quality of medication use target specific drugs or disease states, or a set of pre-defined quality indicators, rather than the patient.
OBJECTIVE
We conducted a prospective cohort study to determine the prevalence and types of medication-related problems in older adults, examining the impact of race on quality medication use.
METHODS
In-home interviews and medical record reviews of 200 (100 white, 100 black) older adults were conducted three times over 1 year. The quality of medication use was measured using a clinical pharmacist’s assessment of quality and the Assessing Care of Vulnerable Elders quality indicators. We used logistic and negative binomial regression models to analyze the two primary endpoints of prevalence and number of medication-related problems.
RESULTS
Mean age was 78.3 (whites) and 75.5 (blacks), with the majority being female. Although whites used more medications than blacks (11.6 versus 9.7; p < 0.01), blacks had more medication-related problems per person than whites (6.2 versus 4.9; p < 0.01). All patients had at least one medication-related problem; undertreatment, suboptimal drug, suboptimal dosing, and nonadherence were most prevalent. Blacks had significantly higher rates of nonadherence than whites (68% versus 42%; p < 0.01).
CONCLUSION
Medication-related problems are prevalent in community-residing older adults. Blacks had more medication-related problems than whites, including higher rates of nonadherence. These findings require further study to better understand racial disparities in quality medication use.
Similar content being viewed by others
References
Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001;38:666–71.
Higashi T, Shekelle PG, Adams JL, et al. Quality of care is associated with survival in vulnerable older patients. Ann Intern Med. 2005;143:274–81.
Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther. 2007;81:235–41.
Fu AZ, Jiang JZ, Reeves JH, Fincham JE, Lin GG, Perri M. Potentially inappropriate medication use and healthcare expenditures in the US community-dwelling elderly. Med Care. 2007;45:472–6.
Johnson JA, Bootman JL. Drug-related morbidity and mortality and the economic impact of pharmaceutical care. Am J Health Syst Pharm. 1997;54:554–8.
Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: Updating the cost-of-illness model. J Am Pharm Assoc. 2001;41:192–9.
Johnson JA, Bootman JL. Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995;155:1949–56.
Smedley BD, Stith AY, Nelson AR, eds, for the Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, the Board on Health Sciences Policy, and the Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2003.
Gaskin DJ, Briesacher BA, Limcangco R, Brigantti BL. Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries. Am J Geriatr Pharmacother. 2006;4:96–111.
Saha S, Freeman M, Toure J, Tippens KM, Weeks C, Ibrahim S. Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med. 2008;23:654–71.
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24.
Knight EL, Avorn J. Quality indicators for appropriate medication use in vulnerable elders. Ann Intern Med. 2001;135:703–10.
Lohr KN, ed, for the Committee to Design a Strategy for Quality Review and Assurance in Medicare, the Division of Health Care Services, and the Institute of Medicine. Medicare: A Strategy for Quality Assurance. Washington, DC: National Academy Press; 1990.
Chassin MR. Quality of care. Time to act. JAMA. 1991;266:3472–3.
Roth MT, Moore CG, Ivey JL, Esserman DA, Campbell WH, Weinberger M. The quality of medication use in older adults: methods of a longitudinal study. Am J Geriatr Pharmacother. 2008;6:220–33.
Callahan CM, Unverzagt FW, Hui SL, Perkins AJ, Hendrie HC. Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002;40:771–81.
Baker DW, Williams MV, Parker RM, Gazmararian JA, Nurss J. Development of a brief test to measure functional health literacy. Patient Educ Couns. 1999;38:33–42.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.
Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP. 1990;24:1093–7.
Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55(Suppl 2):S373–82.
Kerr EA, Smith DM, Hogan MM, et al. Building a better quality measure: are some patients with poor quality actually getting good care? Med Care. 2003;41(10):1173–82.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.
Pagona M, Gauvreau K, eds. Principles of Biostatistics. 2nd ed. Pacific Grove, Calif: Duxbury; 2000.
Hanlon JT, Weinberger M, Samsa GP, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100(4):428–37.
Fillenbaum GG, Hanlon JT. Racial and ethnic disparities in medication use among older adults. Am J Geriatr Pharmacother. 2006 Jun;4(2):93–5.
Murray MD, Young J, Hoke S, et al. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007 May 15;146(10):714–25.
Shrank WH, Asch SM, Adams J, et al. The quality of pharmacologic care for adults in the United States. Med Care. 2006;44:936–45.
Ostrom JR, Hammarlund ER, Christensen DB, Plein JB, Kethley AJ. Medication usage in an elderly population. Med Care. 1985 Feb;23(2):157–64.
Alkema GE, Wilber KH, Simmons WJ, Enguidanos SM, Frey D. Prevalence of potential medication problems among dually eligible older adults in Medicaid waiver services. Ann Pharmacother. 2007 Dec;41(12):1971–8.
Cipolle RJ, Strand LM, Morley PC, eds. Pharmaceutical Care Practice. New York, NY: McGraw-Hill; 2004.
Kassam R, Farris KB, Burback L, Volume CI, Cox CE, Cave A. Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc. 2001;41(3):401–10.
Acknowledgment
Dr. Roth had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
The authors wish to thank Robin H. Zook (RHZ), PharmD, CGP, MTM Pharmacy Associates, for her assistance in subject recruitment, enrollment, and data collection.
The authors wish to thank Ryan Owenby, PharmD, for his assistance in project management and data entry (Ryan was a Doctor of Pharmacy student and a student research assistant, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, when this study was ongoing).
The authors wish to thank John Paul Timmins, MBA, Planning Systems Productivity & Co., for designing, developing, and maintaining the study database.
Funding Sources
Drs. Roth and Ivey receive funding from the National Institutes of Health, National Institute on Aging (Principal Investigator (MTR): Research and Career Development Award). The funding agency has no role in the design and conduct of the study, data collection, management, analysis, interpretation of the data, or preparation, review, or approval of this manuscript.
Drs. Esserman and Weinberger receive funding from the National Institutes of Health (CTSA UL1RR025747). The funding agency has no role in the design and conduct of the study, data collection, management, analysis, interpretation of the data, or preparation, review, or approval of this manuscript.
The study was also supported by an American College of Clinical Pharmacy (ACCP) Frontiers Fund Research and Career Development Award.
Conflict of Interest
There are no conflicts of interest or financial interests to declare for any of the four authors.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Roth, M.T., Esserman, D.A., Ivey, J.L. et al. Racial Disparities in the Quality of Medication Use in Older Adults: Baseline Findings from a Longitudinal Study. J GEN INTERN MED 25, 228–234 (2010). https://doi.org/10.1007/s11606-009-1180-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-009-1180-9